{"status":"OK","data":{"advertisement":{"id":226627,"title":"PB105/PureMax/2023/01\n\u201eProdukcja bia\u0142ka na potrzeby badania klinicznego fazy 0\u201d.\n\u201eProduction of Drug Substance and Drug Product for Phase 0 clinical study\u201d.","partial_offer_allowed":false,"publication_date":"2023-09-11","submission_deadline":"2023-10-11 23:59:59","planned_sign_date":"2023-10-01","supplementary_orders":"-","terms_of_contract_change":null,"created_at":"2023-09-11 13:38:38","modified_at":"2023-10-12 00:00:03","contact_persons":[{"id":3163,"forename":"Karolina","surname":"Miernik","phone_number":"","email":"k.miernik@purebiologics.com","created_by":null,"created_at":"2023-12-05 14:42:15","modified_at":"2023-12-05 14:42:15","modified_by":null}],"orders":[{"id":370760,"estimated_value":null,"order_items":[{"id":419063,"description":"Numer: PB105/PureMax/2023/01\n\nPrzedmiotem zam\u00f3wienia jest zakup us\u0142ugi wytwarzania i oczyszczania rekombinowanych ludzkich przeciwcia\u0142 IgG1 (nazwanych jako monospecyficzne) oraz IgG1 w fuzji z bia\u0142kiem partnerskim (nazwanych jako bifunkcyjne) do bada\u0144 toksyczno\u015bci i fazy 0. Zam\u00f3wienie dotyczy produkcji, formulacji i analizy substancji leczniczej (DS), konwersji DS do produktu leczniczego (DP), badania uwalniania DS i DP, badania stabilno\u015bci DS i DP, pakowania i etykietowania DS i DP (nape\u0142nianie i wyka\u0144czanie DP). \u017badne z dzia\u0142a\u0144 obj\u0119tych niniejsz\u0105 umow\u0105 nie wymaga stosowania cGMP.\nThe subject of the contract is the purchase of the service of production and testing of recombinant human IgG1 antibodies (named monospecific) and IgG1 fused with a partner protein (named bifunctional) for toxicity and Phase-0 study. The order concerns production, formulation and analytics of a drug substance (DS), conversion of DS to drug product (DP), DS and DP release testing, DS and DP stability study, packing and labelling of DS and DP (fill and finish for DP). None of the activities covered by this contract requires cGMP.","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"dolno\u015bl\u0105skie","poviat":"Wroc\u0142aw","commune":"Wroc\u0142aw-Fabryczna","locality":"Wroc\u0142aw","created_by":null,"created_at":"2023-09-11 13:38:38","modified_at":"2023-09-11 13:40:41","modified_by":null,"id":470536,"type":{"id":1,"name":"adres"},"group_uuid":"35c89e78-8dc3-4ead-bd12-ca555d2c3c30"}],"participation_conditions":[{"id":1143936,"description":"Zamawiaj\u0105cy zastrzega, \u017ce oferty mog\u0105 z\u0142o\u017cy\u0107 wy\u0142\u0105cznie Oferenci, kt\u00f3rzy:\na)\tposiadaj\u0105 uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci, je\u017celi prawo nak\u0142ada obowi\u0105zek ich posiadania do wykonywania dzia\u0142alno\u015bci obj\u0119tej zam\u00f3wieniem,\nb)\tposiadaj\u0105 przedstawiciela z wykszta\u0142ceniem biotechnologicznym do kontaktu z Zamawiaj\u0105cym, konsultowania i koordynowania zlece\u0144,         \nc)\tposiadaj\u0105 niezb\u0119dn\u0105 wiedz\u0119 i do\u015bwiadczenie w \u015bwiadczeniu us\u0142ug produkcji i oczyszczania            rekombinowanych przeciwcia\u0142, w tym wytwarzanie przeciwcia\u0142 afukozylowanych,\nd)\tposiadaj\u0105 mo\u017cliwo\u015bci techniczne do produkcji i oczyszczania rekombinowanego przeciwcia\u0142a w wymaganej skali.\n\nThe Ordering Party reserves that tender may only be submitted by the Bidders who declare that: \na.\tare entitled to perform a specific activity, if the provisions of law impose an obligation to hold a permit to perform such activity covered by the contract,\nb.\thave a representative with biotechnology education to contact, consult and coordinate orders with the Ordering Party,\nc.\thave the necessary knowledge and experience in providing production and purification services for recombinant antibodies, including production of afucosylated antibodies,\nd.\thave technical capabilities to produce and purify a recombinant antibody in the required scale.","type":{"id":4,"name":"Osoby zdolne do wykonania zam\u00f3wienia"},"created_by":null,"created_at":"2023-09-11 13:38:38","modified_at":"2023-09-11 13:40:41","modified_by":null,"group_uuid":"3b901a97-1e12-4aed-aa98-550ac4751397"},{"id":1143937,"description":"Oferta powinna zawiera\u0107 podpisane przez osoby upowa\u017cnione za\u0142\u0105czniki, przynajmniej:\na). dokument upowa\u017cniaj\u0105cy/upowa\u017cnienie dla osoby sk\u0142adaj\u0105cej ofert\u0119,\nb). za\u0142\u0105cznik nr 1 - uzupe\u0142niony formularz oferty wraz z o\u015bwiadczeniami dotycz\u0105cymi Oferenta, \nc). za\u0142\u0105cznik nr 2  - o\u015bwiadczenie o braku powi\u0105za\u0144 pomi\u0119dzy podmiotami wsp\u00f3\u0142pracuj\u0105cymi.\n\nThe offer should contain attachments signed by authorized persons, at least:\na)\tdocument authorizing/authorization for the person submitting the offer,\nb)\tAttachment No. 1 \u2013 completed tender form together with statements concerning the Bidder,\nc)\tAttachment No. 2 - statement on the lack of relations between cooperating entities.","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-09-11 13:38:38","modified_at":"2023-09-11 13:40:41","modified_by":null,"group_uuid":"22f79805-3a3f-4ede-86e0-07b2a59326df"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":8,"name":"Us\u0142ugi inne"},"created_by":null,"created_at":"2023-09-11 13:38:38","modified_at":"2023-09-11 13:40:41","modified_by":null,"group_uuid":"26e3c397-fb18-4835-8626-f18c36c39a9d"}],"evaluation_criteria":[{"id":638439,"price_criterion":true,"description":"Cena- 100%\nPrice- 100%","created_by":null,"created_at":"2023-09-11 13:38:38","modified_at":"2023-09-11 13:40:41","modified_by":null,"group_uuid":"1731bdd2-0c6f-4185-b7c9-9e00437a79fe"}],"is_variant":false,"title":"Production","order_node":{"id":281739},"created_by":null,"created_at":"2023-09-11 13:38:38","modified_at":"2023-09-11 13:40:41","modified_by":null}],"created_by":{"id":95,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Pure Biologics S.A.","identification_number_type":"nip","identification_number":"8943003192","address":{"country":"Polska","voivodeship":"dolno\u015bl\u0105skie","poviat":"Wroc\u0142aw","commune":"Wroc\u0142aw-Fabryczna","locality":"Wroc\u0142aw","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":595636,"street":"Du\u0144ska","number_description":"11","postcode":"54-427"},"created_by":{"id":95,"contact_persons":[]},"created_at":"2023-09-11 13:38:38","modified_at":"2023-09-11 13:38:38","modified_by":{"id":95,"contact_persons":[]},"id":227124},"advertisement":{"id":172686,"number":"2023-95-172686","publication_date":"2023-09-11","created_by":{"id":95,"contact_persons":[]},"created_at":"2023-09-11 13:38:38","modified_at":"2023-10-12 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[226627],"enrollment":{"id":41040,"name":"\u201eWsparcie dla przedsi\u0119biorc\u00f3w\u201d","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-09-11 12:43:12","modified_at":"2023-09-11 12:43:12","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":226627,"publication_date":"2023-09-11"},"id":1127334,"name":"Zapytanie ofertowe nr PB105/PureMax/2023/01","file":{"id":1256496,"name":"PB105_PureMax_CMC-zapytanie ofertowe.pdf","created_at":"2023-09-11 13:33:34","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1256496"},"group_uuid":"29015015-2adb-4d29-a9a6-f6a0eaef7b9b"},{"origin":{"id":226627,"publication_date":"2023-09-11"},"id":1127335,"name":"Request for tender No. PB105/PureMax/2023/01","file":{"id":1256499,"name":"PB105_PureMax_CMC-Request for tender ENG.pdf","created_at":"2023-09-11 13:35:04","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1256499"},"group_uuid":"d39ceaed-a71e-4b5a-b74c-cdbaed81d635"},{"origin":{"id":226627,"publication_date":"2023-09-11"},"id":1127336,"name":"Za\u0142\u0105czniki nr 1 i 2 do zapytania ofertowego- wersja do edycji","file":{"id":1256502,"name":"PB105_PureMax_CMC Za\u0142\u0105czniki nr 1 i 2.docx","created_at":"2023-09-11 13:35:47","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1256502"},"group_uuid":"9ccd1e74-ab6b-4ced-9363-7c3b37cc5d96"},{"origin":{"id":226627,"publication_date":"2023-09-11"},"id":1127337,"name":"Attachments no. 1 and 2 - editable version","file":{"id":1256510,"name":"PB105_PureMax_CMC _Att. 1, 2 ENG.docx","created_at":"2023-09-11 13:38:07","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1256510"},"group_uuid":"a215eadb-77ec-4a46-8240-0927c193c63e"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}